MGO One Seven LLC lowered its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 65.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,227 shares of the medical equipment provider’s stock after selling 11,677 shares during the period. MGO One Seven LLC’s holdings in Intuitive Surgical were worth $2,532,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. Gilliland Jeter Wealth Management LLC raised its stake in shares of Intuitive Surgical by 2.1% during the third quarter. Gilliland Jeter Wealth Management LLC now owns 4,808 shares of the medical equipment provider’s stock worth $1,955,000 after buying an additional 100 shares during the last quarter. Greenup Street Wealth Management LLC raised its position in shares of Intuitive Surgical by 1,108.9% in the 3rd quarter. Greenup Street Wealth Management LLC now owns 6,927 shares of the medical equipment provider’s stock valued at $2,817,000 after acquiring an additional 6,354 shares during the period. State of Wyoming boosted its stake in Intuitive Surgical by 18.4% during the 3rd quarter. State of Wyoming now owns 360 shares of the medical equipment provider’s stock worth $146,000 after acquiring an additional 56 shares during the last quarter. Petros Family Wealth LLC lifted its holdings in Intuitive Surgical by 13.5% during the third quarter. Petros Family Wealth LLC now owns 2,617 shares of the medical equipment provider’s stock worth $1,064,000 after acquiring an additional 312 shares in the last quarter. Finally, Arta Finance Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 24.7% during the 3rd quarter. Arta Finance Wealth Management LLC now owns 4,660 shares of the medical equipment provider’s stock valued at $1,895,000 after purchasing an additional 924 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other Intuitive Surgical news, Director Craig Barratt sold 1,150 shares of the company’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total value of $510,370.00. Following the transaction, the director directly owned 1,150 shares of the company’s stock, valued at $510,370. This represents a 50.00% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Mark Brosius sold 61 shares of the company’s stock in a transaction on Wednesday, October 28th. The shares were sold at an average price of $441.60, for a total value of $26,937.60. Following the completion of the transaction, the executive vice president directly owned 581 shares in the company, valued at approximately $256,569.60. This represents a 9.50% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 38,778 shares of company stock worth $16,814,967 over the last three months. 0.60% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on the company. KeyCorp reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Wells Fargo & Company reaffirmed an “overweight” rating and set a $486.00 price target (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Leerink Partners set a $503.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 21st. Barclays reissued an “overweight” rating and issued a $500.00 price objective (up from $485.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Finally, BTIG Research restated a “buy” rating and set a $454.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $493.54.
Get Our Latest Analysis on Intuitive Surgical
Intuitive Surgical Stock Up 0.9%
Intuitive Surgical stock opened at $440.75 on Wednesday. The company’s 50-day moving average price is $404.05 and its two-hundred day moving average price is $432.90. The stock has a market cap of $152.78 billion, a P/E ratio of 53.30, a P/E/G ratio of 3.01 and a beta of 1.45. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The company had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter in the previous year, the company posted $2.40 earnings per share. The business’s revenue was up 21.7% on a year-over-year basis. Equities analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.
About Intuitive Surgical
Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.
The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- Marriott’s Earnings Beat Shows Why It’s More Than a Bet on Travel Demand
- Franklin Templeton’s New ETFs Turn Stock Dividends Into Bitcoin—What’s the Catch?
- Apple’s Earnings Beat Comes With a Catch for Investors Heading Into the Holidays
- Palantir’s $2.3 Billion Quarter Puts Its Premium Valuation to the Test
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
